South Shore Capital Advisors

Position in MRK — Merck & Co., Inc.

CIK 1852993 COHASSET, MA

Position in MRK

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$449,493

+$39,545 QoQ

Shares Held

3,498

+2.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.40%

of 13F equity value

Holder Rank

#2,782

of 3,768 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

South Shore Capital Advisors holds $5,027,059 across 5 Drug Manufacturers - General names. MRK ranks #4 (8.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	13,605	$3,455,261
2	LLY	ELI LILLY & Co	387	$464,179
3	NVS	Novartis AG	2,870	$449,786
4	MRK	Merck & Co., Inc. This page	3,498	$449,493
5	PFE	Pfizer Inc	8,652	$208,340

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$449,493	3,498	+2.6%	Shares	Sole	2026-07-30
2026-03-31	$409,948	3,408	—	Shares	Sole	2026-04-28
No filing history on record for this holder in this stock.